These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34442810)

  • 1. The New Generation
    Calistri A; Luganini A; Mognetti B; Elder E; Sibille G; Conciatori V; Del Vecchio C; Sainas S; Boschi D; Montserrat N; Mirazimi A; Lolli ML; Gribaudo G; Parolin C
    Microorganisms; 2021 Aug; 9(8):. PubMed ID: 34442810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Novel
    Sibille G; Luganini A; Sainas S; Boschi D; Lolli ML; Gribaudo G
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of antiviral activity of the new hDHODH inhibitor MEDS433 against respiratory syncytial virus replication.
    Luganini A; Sibille G; Pavan M; Mello Grand M; Sainas S; Boschi D; Lolli ML; Chiorino G; Gribaudo G
    Antiviral Res; 2023 Nov; 219():105734. PubMed ID: 37852322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication.
    Luganini A; Sibille G; Mognetti B; Sainas S; Pippione AC; Giorgis M; Boschi D; Lolli ML; Gribaudo G
    Antiviral Res; 2021 May; 189():105057. PubMed ID: 33716051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antivirals for Broader Coverage against Human Coronaviruses.
    Outteridge M; Nunn CM; Devine K; Patel B; McLean GR
    Viruses; 2024 Jan; 16(1):. PubMed ID: 38275966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Strategies of Antiviral Drug Discovery for COVID-19.
    Mei M; Tan X
    Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomic profiling and genomic mutational analysis of Human coronavirus (HCoV)-229E -infected human cells.
    Friedman N; Jacob-Hirsch J; Drori Y; Eran E; Kol N; Nayshool O; Mendelson E; Rechavi G; Mandelboim M
    PLoS One; 2021; 16(2):e0247128. PubMed ID: 33630927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating theobromine as a potential anti-human coronaviral agent.
    Li J; Wang Y; Rajpoot S; Lavrijsen M; Pan Q; Li P; Baig MS
    Microbiol Immunol; 2023 Sep; 67(9):404-412. PubMed ID: 37415325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bivalent protein targeting glycans and HR1 domain in spike protein potently inhibited infection of SARS-CoV-2 and other human coronaviruses.
    Cai Y; Xu W; Tang J; Cao N; Lan Q; Lu L; Jiang S
    Cell Biosci; 2021 Jul; 11(1):128. PubMed ID: 34238357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2.
    Pasquero S; Gugliesi F; Griffante G; Dell'Oste V; Biolatti M; Albano C; Bajetto G; Delbue S; Signorini L; Dolci M; Landolfo S; De Andrea M
    Antiviral Res; 2022 Apr; 200():105278. PubMed ID: 35288208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan.
    Kubota-Koketsu R; Terada Y; Yunoki M; Sasaki T; Nakayama EE; Kamitani W; Shioda T
    Transfusion; 2021 Feb; 61(2):356-360. PubMed ID: 33104267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposing dyphylline as a pan-coronavirus antiviral therapy.
    Wang Y; Rajpoot S; Li P; Lavrijsen M; Ma Z; Hirani N; Saqib U; Pan Q; Baig MS
    Future Med Chem; 2022 May; 14(10):685-699. PubMed ID: 35387498
    [No Abstract]   [Full Text] [Related]  

  • 13. Properties of Coronavirus and SARS-CoV-2.
    Malik YA
    Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brequinar and dipyridamole in combination exhibits synergistic antiviral activity against SARS-CoV-2 in vitro: Rationale for a host-acting antiviral treatment strategy for COVID-19.
    Demarest JF; Kienle M; Boytz R; Ayres M; Kim EJ; Patten JJ; Chung D; Gandhi V; Davey RA; Sykes DB; Shohdy N; Pottage JC; Kumar VS
    Antiviral Res; 2022 Oct; 206():105403. PubMed ID: 36041646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing old drugs as antiviral agents for coronaviruses.
    Yang CW; Peng TT; Hsu HY; Lee YZ; Wu SH; Lin WH; Ke YY; Hsu TA; Yeh TK; Huang WZ; Lin JH; Sytwu HK; Chen CT; Lee SJ
    Biomed J; 2020 Aug; 43(4):368-374. PubMed ID: 32563698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing carrimycin as an antiviral agent against human coronaviruses, including the currently pandemic SARS-CoV-2.
    Yan H; Sun J; Wang K; Wang H; Wu S; Bao L; He W; Wang D; Zhu A; Zhang T; Gao R; Dong B; Li J; Yang L; Zhong M; Lv Q; Qin F; Zhuang Z; Huang X; Yang X; Li Y; Che Y; Jiang J
    Acta Pharm Sin B; 2021 Sep; 11(9):2850-2858. PubMed ID: 33723501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Patent Review of Human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors as Anticancer Agents and their Other Therapeutic Applications (1999-2022).
    Gehlot P; Vyas VK
    Recent Pat Anticancer Drug Discov; 2024; 19(3):280-297. PubMed ID: 37070439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.
    Demers-Mathieu V; DaPra C; Mathijssen G; A Sela D; M Jarvinen K; Seppo A; Fels S; Medo E
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.
    Zhou J; Xu W; Liu Z; Wang C; Xia S; Lan Q; Cai Y; Su S; Pu J; Xing L; Xie Y; Lu L; Jiang S; Wang Q
    Acta Pharm Sin B; 2022 Apr; 12(4):1652-1661. PubMed ID: 34367893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.
    Goyal B; Goyal D
    ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.